Whitehawk Therapeutics (3350.MU) Q3 2026 Earnings

12AugConfirmed
Q2 2026
Next
-0.3
-0.29
-0.28
-0.27

Details

Expected EPS
-0.27510337859999995
Actual EPS
N/A
Surprise EPS
0.28
Surprise Percent
+100%

Description

Whitehawk Therapeutics (3350.MU) will report earnings of for Q3 2026 on August 12, 2026.

0 Comments

Share your thoughts